MVIS® US Listed Pharmaceutical 25 Index

The MVIS® US Listed Pharmaceutical 25 Index (MVPPH) tracks the performance of the 25 largest and most liquid US exchange-listed companies in the pharmaceutical industry. This is a modified market cap-weighted index, and only includes companies that generate at least 50% of their revenue from pharmaceutical related products and services, such as research and development, production, or marketing and sales.

Components

The MVIS® US Listed Pharmaceutical 25 Index counts currently 26 components. The full list of the components with the respective weights (as of latest close) is available below.

Items 1-26 of total 26
Items 1-26 of total 26
Up